Number To Know…30,000,000
$30m is the amount of equity financing raised by Cardiva Medical to fund commercialization of its VASCADE vascular closure system.
Cardiva Medical announced March 14 that it raised $30m in equity funds to expand commercialization of its CE-marked and US FDA-approved VASCADE vascular closure system. The VASCADE family of disposable devices is designed to deliver a resorbable collagen patch extravascularly to the arteriotomy site to facilitate hemostasis at the completion of a catheterization procedure. These devices are intended to assist physicians or catheter lab technicians in controlling bleeding from femoral arteriotomy sites and are intended to reduce time to hemostasis, time to ambulation, and time to discharge eligibility. The VASCADE catheter is introduced through the existing sheath at the completion of a catheterization procedure.
Meddevicetracker subscribers can access a full analysis of Cardiva's product portfolio, including the clinical and regulatory status of the VASCADE Vascular Closure System, here.
Not a subscriber? Click here to request your free demo.